Project Details


The objective of this Phase I study is to determine the maximum tolerated doses (MTD) of docetaxel and carboplatin in combination, when given to patients with advanced solid tumors.
Effective start/end date10/1/959/30/97


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.